Michael Silverman

524 total citations
24 papers, 348 citations indexed

About

Michael Silverman is a scholar working on Surgery, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Michael Silverman has authored 24 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 8 papers in Infectious Diseases and 5 papers in Molecular Biology. Recurrent topics in Michael Silverman's work include Clostridium difficile and Clostridium perfringens research (5 papers), Gut microbiota and health (4 papers) and Syphilis Diagnosis and Treatment (2 papers). Michael Silverman is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (5 papers), Gut microbiota and health (4 papers) and Syphilis Diagnosis and Treatment (2 papers). Michael Silverman collaborates with scholars based in United States, Canada and Denmark. Michael Silverman's co-authors include Andrew Wong, Dea Shahinas, Taylor Sittler, Charles Y. Chiu, Peter Kim, J. Scott Weese, Donald E. Low, Emma Allen‐Vercoe, Dylan R. Pillai and Adrian Budhram and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Michael Silverman

22 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Silverman United States 9 152 146 79 63 61 24 348
Anthony Albanese United States 8 97 0.6× 113 0.8× 101 1.3× 20 0.3× 21 0.3× 13 345
Halil Kocamaz Türkiye 12 58 0.4× 50 0.3× 120 1.5× 58 0.9× 58 1.0× 30 408
Serge Makarenko Canada 9 91 0.6× 37 0.3× 95 1.2× 78 1.2× 22 0.4× 31 298
Ogechukwu Menkiti United States 6 272 1.8× 105 0.7× 70 0.9× 45 0.7× 28 0.5× 20 529
Xuan Jiang China 9 51 0.3× 105 0.7× 209 2.6× 107 1.7× 89 1.5× 25 554
Christine Lee Canada 10 64 0.4× 129 0.9× 140 1.8× 88 1.4× 38 0.6× 22 340
Blair Merrick United Kingdom 9 173 1.1× 140 1.0× 42 0.5× 50 0.8× 48 0.8× 25 348
Jonathan Plassais France 9 194 1.3× 39 0.3× 158 2.0× 49 0.8× 12 0.2× 9 421
Maria J. G. T. Vehreschild Germany 10 175 1.2× 64 0.4× 164 2.1× 33 0.5× 34 0.6× 20 329
Chan‐Hoo Park South Korea 11 47 0.3× 114 0.8× 53 0.7× 137 2.2× 53 0.9× 62 386

Countries citing papers authored by Michael Silverman

Since Specialization
Citations

This map shows the geographic impact of Michael Silverman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Silverman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Silverman more than expected).

Fields of papers citing papers by Michael Silverman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Silverman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Silverman. The network helps show where Michael Silverman may publish in the future.

Co-authorship network of co-authors of Michael Silverman

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Silverman. A scholar is included among the top collaborators of Michael Silverman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Silverman. Michael Silverman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sims, Matthew, Michael Silverman, Thomas Louie, et al.. (2023). Integrated efficacy analysis from phase 3 studies of investigational microbiome therapeutic, SER-109, in recurrent Clostridioides difficile infection. SHILAP Revista de lepidopterología. 3(S2). s5–s5. 1 indexed citations
2.
Sleiman, Joseph, Ruishen Lyu, Amit Bhatt, et al.. (2021). Clinically actionable findings on surveillance EGD in asymptomatic patients with Lynch syndrome. Gastrointestinal Endoscopy. 95(1). 105–114. 14 indexed citations
3.
Silverman, Michael, et al.. (2021). Retrospective Review of Perioperative Multimodal Analgesia for Orthopedic Patients in a Veterans Affairs Setting. The Senior Care Pharmacist. 36(8). 397–408. 1 indexed citations
4.
5.
Feuerstadt, Paul, et al.. (2020). S0142 Antibiotics Do Not Improve Outcomes in Colon Ischemia (CI) - Results from a Large Retrospective Multi-Center Study. The American Journal of Gastroenterology. 115(1). S68–S68. 1 indexed citations
6.
Silverman, Michael, et al.. (2019). Older patients are significantly more likely to have colon ischaemia‐associated conditions that are chronic and complex. Alimentary Pharmacology & Therapeutics. 49(12). 1502–1508. 3 indexed citations
7.
8.
Parvathy, Seema Nair, et al.. (2018). Su1553 - Impact of Fecal Microbial Transplantation on Intestinal Permeability in Non Alcoholic Fatty Liver Disease. Gastroenterology. 154(6). S–1176. 1 indexed citations
9.
Hosseini‐Moghaddam, Seyed M., et al.. (2017). Infectious diseases specialist management improves outcomes for outpatients diagnosed with cellulitis in the emergency department: a double cohort study. Diagnostic Microbiology and Infectious Disease. 87(4). 371–375. 21 indexed citations
10.
Budhram, Adrian, et al.. (2017). Bilateral Cavernous Sinus Thrombosis in Lemierre’s Syndrome. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 44(4). 424–426. 5 indexed citations
11.
Silverman, Michael, et al.. (2017). Biomechanic Factors Associated With Orbital Floor Fractures. JAMA Facial Plastic Surgery. 19(4). 298–302. 20 indexed citations
12.
Chanyi, Ryan M., Laura J. Craven, Brandon K. Harvey, et al.. (2017). Faecal microbiota transplantation: Where did it start? What have studies taught us? Where is it going?. SAGE Open Medicine. 5. 2104780712–2104780712. 11 indexed citations
13.
Budhram, Adrian, Seema Nair Parvathy, Marcelo Kremenchutzky, & Michael Silverman. (2016). Breaking down the gut microbiome composition in multiple sclerosis. Multiple Sclerosis Journal. 23(5). 628–636. 34 indexed citations
14.
Cherniak, William & Michael Silverman. (2014). Syphilitic Gumma. New England Journal of Medicine. 371(7). 667–667. 5 indexed citations
15.
Ghamande, Sharad, Michael Silverman, Michael A. Gold, et al.. (2007). A phase II randomized, double-blind, placebo-controlled trial of clinical activity and safety of Å6 in patients with asymptomatic CA 125 progression of epithelial ovarian, fallopian tube, or primary peritoneal cancer. Journal of Clinical Oncology. 25(18_suppl). 16014–16014. 1 indexed citations
16.
Silverman, Michael & Stuart A. Rice. (1995). Ethical Dilemmas of Working with Individuals Who Have HIV Disease. Journal of Gay & Lesbian Social Services. 3(4). 53–68. 1 indexed citations
17.
Ronald, Allan, Michael Silverman, J. Allen McCutchan, Lawrence Corey, & H. Hunter Handsfield. (1992). Evaluation of New Anti-Infective Drugs for the Treatment of Syphilis. Clinical Infectious Diseases. 15(Supplement_1). S140–S147. 18 indexed citations
18.
Siegel, Irwin M. & Michael Silverman. (1983). Fully Contoured Seating for the Wheelchair-bound Patient with Neuromuscular Disease. Physical Therapy. 63(10). 1625–1626. 2 indexed citations
19.
Silverman, Michael, et al.. (1982). THE CHICAGO INSERT. Journal of Pediatric Orthopaedics. 2(3). 341–341.
20.
Silverman, Michael, et al.. (1982). Treatment of methanol poisoning with ethanol and hemodialysis.. PubMed. 126(12). 1391–4. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anthony Albanese Breakdown of academic impact, for papers by Halil Kocamaz Breakdown of academic impact, for papers by Serge Makarenko Breakdown of academic impact, for papers by Ogechukwu Menkiti Breakdown of academic impact, for papers by Xuan Jiang Breakdown of academic impact, for papers by Christine Lee Breakdown of academic impact, for papers by Blair Merrick Breakdown of academic impact, for papers by Jonathan Plassais Breakdown of academic impact, for papers by Maria J. G. T. Vehreschild Breakdown of academic impact, for papers by Chan‐Hoo Park
Rankless by CCL
2026